APA (7th ed.) Citation

Dougados, M., Claudepierre, P., Goupille, P., Saraux, A., Tournadre, A., Wendling, D., . . . Lardy-Cleaud, A. Impact of the time of initiation and line of biologic therapy on the retention rate of secukinumab in axial spondyloarthritis (axSpA): Data from the French multicentre retrospective FORSYA study. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Dougados, Maxime, et al. Impact of the Time of Initiation and Line of Biologic Therapy on the Retention Rate of Secukinumab in Axial Spondyloarthritis (axSpA): Data from the French Multicentre Retrospective FORSYA Study. BMJ Publishing Group.

MLA (9th ed.) Citation

Dougados, Maxime, et al. Impact of the Time of Initiation and Line of Biologic Therapy on the Retention Rate of Secukinumab in Axial Spondyloarthritis (axSpA): Data from the French Multicentre Retrospective FORSYA Study. BMJ Publishing Group.